title: Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease.
authors.forename: Kalyan Ram
authors.initials: KR
authors.lastname: Bhamidimarri
authors.affiliation: University of Miami, Division of Medicine, Department of Hepatology, United States.
authors.forename: Bhamidimarri
authors.initials: B
authors.lastname: Kalyan Ram
authors.forename: Frank
authors.initials: F
authors.lastname: Czul
authors.affiliation: University of Miami, Division of Medicine, Department of Hepatology, United States. Electronic address: Frank.czulgurdian@jhsmiami.org.
authors.forename: Czul
authors.initials: C
authors.lastname: Frank
authors.forename: Adam
authors.initials: A
authors.lastname: Peyton
authors.affiliation: University of Miami, Division of Medicine, Department of Hepatology, United States.
authors.forename: Peyton
authors.initials: P
authors.lastname: Adam
authors.forename: Cynthia
authors.initials: C
authors.lastname: Levy
authors.affiliation: University of Miami, Division of Medicine, Department of Hepatology, United States.
authors.forename: Levy
authors.initials: L
authors.lastname: Cynthia
authors.forename: Maria
authors.initials: M
authors.lastname: Hernandez
authors.affiliation: University of Miami, Division of Medicine, Department of Hepatology, United States.
authors.forename: Hernandez
authors.initials: H
authors.lastname: Maria
authors.forename: Lennox
authors.initials: L
authors.lastname: Jeffers
authors.affiliation: University of Miami, Division of Medicine, Department of Hepatology, United States.
authors.forename: Jeffers
authors.initials: J
authors.lastname: Lennox
authors.forename: David
authors.initials: D
authors.lastname: Roth
authors.affiliation: University of Miami, Division of Medicine, Department of Nephrology, United States.
authors.forename: Roth
authors.initials: R
authors.lastname: David
authors.forename: Eugene
authors.initials: E
authors.lastname: Schiff
authors.affiliation: University of Miami, Division of Medicine, Department of Hepatology, United States.
authors.forename: Schiff
authors.initials: S
authors.lastname: Eugene
authors.forename: Christopher
authors.initials: C
authors.lastname: O'Brien
authors.affiliation: University of Miami, Division of Medicine, Department of Hepatology, United States.
authors.forename: O'Brien
authors.initials: O
authors.lastname: Christopher
authors.affiliation: University of Miami, Division of Medicine, Department of Hepatology, United States.
authors.forename: Paul
authors.initials: P
authors.lastname: Martin
authors.forename: Martin
authors.initials: M
authors.lastname: Paul
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D000069616:Simeprevir / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000069474:Sofosbuvir / Q000008:administration & dosage* / Q000493:pharmacokinetics
chemical_list: D000998:Antiviral Agents; D000069616:Simeprevir; D000069474:Sofosbuvir